HCA Healthcare Overview
HCA Healthcare Target Price
Analysts' 12-month price predictions for HCA.
Share Price
$308.84
Average Target Price
$344.33
11.5% upside
11.5% upside3 analysts in the last 4 months
High: $359 | Low: $329
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2024-04-29 | OppenheimerMichael Wiederhorn | $345 | 11.7% upside |  |
| 2024-04-29 | RBC CapitalBen Hendrix | $329 | 6.5% upside | |
| 2024-04-12 | Deutsche BankPito Chickering | $359 | 16.2% upside | |
| 2023-04-24 | Mizuho SecuritiesAnn Hynes | $298 |  3.5% downside | |
| 2023-04-24 | OppenheimerMichael Wiederhorn | $310 | 0.4% upside | |
| 2023-04-24 | RBC CapitalBen Hendrix | $315 | 2% upside | |
| 2023-02-08 | Goldman Sachs | $296 | 4.2% downside | |
| 2023-01-13 | UBS | $296 | 4.2% downside | |
| 2023-01-03 | Wells Fargo | $243 | 21.3% downside | |
| 2022-12-16 | Leerink Partners | $286 | 7.4% downside | |
| 2022-12-12 | Goldman Sachs | $265 | 14.2% downside | |
| 2022-09-16 | Raymond James | $250 | 19.1% downside | |
| 2022-08-24 | Leerink Partners | $259 | 16.1% downside | |
| 2022-08-16 | Mizuho SecuritiesAnn Hynes | $230 | 25.5% downside | |
| 2022-07-28 | Wells Fargo | $199 | 35.6% downside | |
| 2022-07-26 | Raymond James | $230 | 25.5% downside | |
| 2022-07-25 | Truist Financial | $240 | 22.3% downside | |
| 2022-07-25 | RBC Capital | $249 | 19.4% downside | |
| 2022-07-25 | Credit Suisse | $250 | 19.1% downside | |
| 2022-07-25 | Leerink Partners | $240 | 22.3% downside | |
| 2022-07-15 | Leerink Partners | $212 | 31.4% downside | |
| 2022-07-12 | Goldman Sachs | $233 | 24.6% downside | |
| 2022-07-11 | Raymond James | $220 | 28.8% downside | |
| 2022-07-07 | Deutsche Bank | $200 | 35.2% downside | |
| 2022-07-01 | Mizuho Securities | $210 | 32% downside | |
| 2022-06-21 | RBC Capital | $256 | 17.1% downside | |
| 2022-06-16 | Loop Capital MarketsJoseph France | $240 | 22.3% downside | |
| 2022-05-03 | Mizuho Securities | $260 | 15.8% downside | |
| 2022-04-28 | BMO CapitalMatt Borsch | $240 | 22.3% downside | |
| 2022-04-26 | Raymond James | $245 | 20.7% downside | |
| 2022-04-26 | UBS | $241 | 22% downside | |
| 2022-04-25 | RBC Capital | $267 | 13.5% downside | |
| 2022-04-25 | Wells FargoSteve Baxter | $227 | 26.5% downside | |
| 2022-04-25 | Truist Financial | $250 | 19.1% downside | |
| 2022-04-25 | Wells Fargo | $227 | 26.5% downside | |
| 2022-04-25 | Credit Suisse | $260 | 15.8% downside | |
| 2022-04-25 | Leerink Partners | $273 | 11.6% downside | |
| 2022-04-25 | Citigroup | $254 | 17.8% downside | |
| 2022-04-22 | BarclaysSarah James | $256 | 17.1% downside | |
| 2022-04-22 | Mizuho SecuritiesAnn Hynes | $290 | 6.1% downside | |
| 2022-01-05 | Truist FinancialDavid S Macdonald | $310 | 0.4% upside | |
| 2022-01-04 | JefferiesBrian Tanquilut | $310 | 0.4% upside | |
| 2021-12-21 | J.P. MorganLisa Gill | $270 | 12.6% downside | |
| 2021-12-20 | Mizuho SecuritiesAnn Hynes | $290 | 6.1% downside | |
| 2021-10-26 | Raymond JamesJohn Ransom | $300 | 2.9% downside | |
| 2021-10-25 | Deutsche BankPito Chickering | $306 | 0.9% downside | |
| 2021-10-25 | OppenheimerMichael Wiederhorn | $290 | 6.1% downside | |
| 2021-08-16 | BarclaysSarah James | $275 | 11% downside | |
| 2021-08-02 | Argus ResearchJasper Hellweg | $275 | 11% downside | |
| 2021-06-21 | Wolfe ResearchJustin Lake | $224 | 27.5% downside | |